Agfa HealthCare has announced the debut of IMPAX Clinical Applications 2.1, a suite of advanced image processing and 3D rendering tools. Using its foundation of experience with more than 2,000 IMPAX PACS installations worldwide, Agfa HealthCare has designed the product to address the clinical needs of radiologists and clinicians by integrating the advanced processing applications directly into the IMPAX PACS workflow.
"IMPAX Clinical Applications 2.1 is a win facility-wide because of its unique combination of clinical efficiency and cost benefits," said Lenny J. Reznik, Director of Enterprise Imaging and Information, Agfa HealthCare, U.S. "Now when radiologists are interpreting large, complex exams, they can have the benefit of Agfa HealthCare's advanced processing tools integrated right into their workflow and at the point of care for more informed healthcare delivery. And because the solution is offered modularly, it is cost-effective by enabling a healthcare facility to add only those tools that their physicians use most often."
Improved Efficiency, Faster Availability
IMPAX Clinical Applications 2.1 enables more efficient and rapid availability of results because all reading and reporting tools are integrated directly within the IMPAX workflow and on one desktop. Users can switch between applications without reloading study images, and access to priors for comparative data sets is just a click away.
Other noted improvements of IMPAX Clinical Applications 2.1 are:
- Familiar and consistent IMPAX user interface for ease of use and deployment
- Flexible presentation layouts that adapt to workflows
- Completely new framework, resulting in better performance, improved stability, and easier maintenance
- Ability to export new series and or movies to original study
- Modular offering ranging from basic MIP-MPR functionality to advanced multi-modality PET-CT viewing
- Live restore capability that supports interrupted workflow
- Automatic selection of CPU or GPU for faster 3D volume rendering
- Comparative study viewing modes with automatic and manual series registration, and synchronized views for side-by-side 3D viewing
- Addition of IMPAX Vessel Viewing for CTA reporting
Easy to Deploy, Cost-Effective Solution
The product is fully modular to provide radiologists with a selection of the tools they use most frequently, and thus provide a cost-effective pricing structure for healthcare facilities. It is easy to deploy and maintain, requiring no specialized display cards, which is key for those applications that are used on a large number of workstations such as the MIP-MPR functionality. Other modules available include 3D, advanced 3D with comparative mode, vessel analysis, registration and fusion, PET-CT viewing and IMPAX Virtual Colonoscopy*.
IMPAX Clinical Applications 2.1 is scheduled to be available globally starting December 2011.
* IMPAX Virtual Colonoscopy is not available in the United States
Related news articles:
- Agfa HealthCare's Profile
About Agfa
The Agfa-Gevaert Group is one of the world's leading companies in imaging and information technology. Agfa develops manufactures and markets analogue and digital systems for the printing industry (Agfa Graphics), for the healthcare sector (Agfa HealthCare), and for specific industrial applications (Agfa Materials). Agfa is headquartered in Mortsel, Belgium. The company is present in 40 countries and has agents in another 100 countries around the globe. The Agfa-Gevaert Group achieved a turnover of 2,948 million euro in 2010.
About Agfa HealthCare
Agfa HealthCare, a member of the Agfa-Gevaert Group, is a leading global provider of diagnostic imaging and healthcare IT solutions. The company has nearly a century of healthcare experience and has been a pioneer on the healthcare IT market since the early 1990's. Today Agfa HealthCare designs, develops and delivers state-of-the-art systems for capturing, managing and processing diagnostic images and clinical/administrative information for hospitals and healthcare facilities, as well as contrast media solutions to enable effective medical imaging results. The company has sales offices and agents in over 100 markets worldwide. Sales for Agfa HealthCare in 2010 were 1,180 million euro.